Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Clinical Chemistry
Emerging Technology
Immunoassays
Molecular Diagnostics
Pathology & AI
Molecular Diagnostics
BillionToOne secures $140M financing agreement with Oberland Capital
By
LabPulse.com staff writers
Molecular diagnostics firm BillionToOne has signed a $140 million nondilutive financing agreement with Oberland Capital Management.
September 5, 2024
Seegene, Springer Nature launch PCR innovation program
By
LabPulse.com staff writers
Molecular diagnostics firm Seegene and Springer Nature have launched a new project for the development of diagnostic assays, as part of their ongoing strategic partnership.
September 3, 2024
Upcoming lung cancer molecular testing guidelines address 7 questions
By
Liz Carey
Revised guideline addresses next-generation sequencing and expanded biomarker testing.
August 28, 2024
CDC prioritizes mpox specimens for testing laboratories
By
LabPulse.com staff writers
The CDC recommended that all laboratories performing mpox testing send certain types of clinical specimens to a laboratory that can perform clade-specific testing as quickly as possible.
August 28, 2024
Seegene develops two RUO mpox assays
By
LabPulse.com staff writers
Seegene has developed two polymerase chain reaction (PCR) test assays for mpox research testing.
August 26, 2024
Scale Bio launches 100M cell challenge research initiative
By
LabPulse.com staff writers
Scale Biosciences, in collaboration with Ultima Genomics and Nvidia, has launched a global initiative for single-cell research projects aimed at collectively analyzing 100 million cells or more across diverse biological systems and research areas.
August 19, 2024
CDC, WHO update on mpox outbreak
By
LabPulse.com staff writers
The Centers for Disease Control and Prevention (CDC) recommended clinicians and jurisdictions in the U.S. maintain a heightened index of suspicion for monkeypox (mpox).
August 14, 2024
Oxford Nanopore to collaborate on Singapore's national sequencing initiative
By
LabPulse.com staff writers
Oxford Nanopore will participate in Singapore's National Precision Medicine program, which is aimed at developing a comprehensive genetic catalog of the country's population.
August 6, 2024
Diagnostic laboratory joint venture expands RNA sequencing at Baylor
By
LabPulse.com staff writers
WT RNAseq goes beyond the interpretation of already identified variants by whole exome sequencing (WES) or whole genome sequencing (WGS), according to Baylor Genetics.
August 6, 2024
Labcorp gets FDA de novo authorization for solid tumor mutation liquid biopsy test
By
LabPulse.com staff writers
Labcorp has received de novo marketing authorization from the U.S. Food and Drug Administration (FDA) for its PGDx Elio Plasma Focus Dx kitted assay, a pan-solid tumor liquid biopsy test that enables tumor mutation profiling.
August 5, 2024
Mercy Bioanalytics wins Disruptive Technology Award competition at ADLM 2024
By
LabPulse.com staff writers
Cancer diagnostics company Mercy Bioanalytics won the Disruptive Technology Award Competition for its blood-based cancer screening technology at the Association for Diagnostics & Laboratory Medicine's (ADLM) annual meeting in Chicago on July 30.
July 30, 2024
Vertex sues HHS for Casgevy fertility program access
By
LabPulse.com staff writers
Vertex Pharmaceuticals filed a lawsuit against the U.S. Department of Health and Human Services seeking to be permitted to offer its fertility support services program to Medicaid patients who have been prescribed its Casgevy gene-editing treatment.
July 16, 2024
Page 1 of 196
Next Page